title: Fructosamine levels and hyperglycemia in preterm neonates.
abstract: BACKGROUND
  Hyperglycemia is a common complication of prematurity, which requires attention because of its high prevalence and multiple consequences. Serum fructosamine used in diabetic patients provides information about the average glucose concentration in the preceding period of 2-3 weeks.
  
  
  OBJECTIVE
  We investigated the physiologic characteristics of a glycemic marker, fructosamine, in preterm and term neonates. We also studied its association with hyperglycemia and related morbidities of preterm infants.
  
  
  METHODS
  Fructosamine levels of 22 extremely premature (gestational age, GA: 25.8 +/- 1.0 weeks), 36 moderately premature (GA: 29.8 +/- 1.3 weeks) and 26 term infants (GA: 39.1 +/- 1.3 weeks) were determined in the 1st week of life. Fructosamine assay was repeated in all preterm neonates in the 4th and 7th postnatal weeks. Hyperglycemic episodes and main morbidities of preterm infants were recorded and analyzed in association with fructosamine levels.
  
  
  RESULTS
  Preterm infants had higher fructosamine levels after birth compared to term infants and a postnatal fall was observed. Serum fructosamine did not show association with the occurrence of hyperglycemia or its main morbidities in preterm infants.
  
  
  CONCLUSIONS
  In the framework of our study, we could not confirm the usefulness of fructosamine determination in the glycemic control of preterm neonates during the perinatal period.
authors.affiliation: Department of Obstetrics and Gynecology, Faculty of Medicine, University of Pecs, Pecs, Hungary. judit.gyarmati@aok.pte.hu
authors.forename: Judit
authors.initials: J
authors.lastname: Gyarmati
authors.forename: Margit
authors.initials: M
authors.lastname: Tokes-Fuzesi
authors.forename: Gabor L
authors.initials: GL
authors.lastname: Kovacs
authors.forename: Valeria
authors.initials: V
authors.lastname: Gaal
authors.forename: Gabriella
authors.initials: G
authors.lastname: Vida
authors.forename: Tibor
authors.initials: T
authors.lastname: Ertl
mesh_terms: D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D016022:Case-Control Studies; D005260:Female; D019270:Fructosamine / Q000097:blood*; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D006943:Hyperglycemia / Q000097:blood* / Q000175:diagnosis*; D015994:Incidence; D007231:Infant, Newborn / Q000097:blood*; D007234:Infant, Premature / Q000097:blood*; D008297:Male
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D019270:Fructosamine; D006442:Glycated Hemoglobin